Sign in Subscribe
Cancer

Magnetoelectric Nanoparticles Show Promise in Cancer Therapy

Strategic Insights

— 1 min read

Researchers at the University of Miami have published a review article in the journal Nanomedicine, highlighting the potential of magnetoelectric nanoparticles (MENPs) in cancer therapy. According to the study, MENPs, which generate electric fields in response to magnetic fields, can be used to target and destroy cancer cells without causing systemic toxicity. The literature search included recent advances in MENP synthesis, optimization of material composition and morphology, and preclinical studies demonstrating their ability to enhance drug delivery, disrupt tumor cell membranes, and induce tumor regression.

Key Takeaways:

  • MENPs are a promising option for precision oncology, offering remote control over therapeutic effects and the potential to overcome limitations of conventional treatments.
  • MENPs can be used to enhance drug delivery, disrupt tumor cell membranes, and induce tumor regression without systemic toxicity.
  • Ongoing research should focus on optimizing MENP design for selectivity and efficacy, as well as advancing their clinical translation for cancer therapy.
  • The literature search included recent advances in MENP synthesis, optimization of material composition and morphology, and preclinical studies.
  • The review article highlighted the potential of MENPs to overcome limitations of conventional cancer treatments, such as off-target effects and drug resistance.
  • Significant progress has been made in the development of MENPs, with a focus on optimizing their design for clinical translation.

Statistics:

  • 2025: The year in which the research was published.
  • 20(19): The volume and issue number of the journal Nanomedicine in which the article was published.
  • 2469-2481: The page numbers of the article "Mechanism and applications of magnetoelectric nanoparticles in cancer therapy" in the journal Nanomedicine.
  • 2-4 Park Square, Milton Park, Abingdon OR14 4RN, Oxon, England: The address of the publisher, Taylor and Francis Ltd.
  • The University of Miami: The institution at which the research was conducted.
  • Coral Gables, FL, United States: The location of the University of Miami.

Sources:

  • Nanomedicine, 2025;20(19):2469-2481.
  • Taylor & Francis Ltd, 2-4 Park Square, Milton Park, Abingdon OR14 4RN, Oxon, England. (Elsevier - www.elsevier.com; Nanomedicine - www.journals.elsevier.com/nanomedicine-nanotechnology-biology-and-medicine/)
  • John Bryant, Dept. of Electrical Engineering, University of Miami, Coral Gables, FL, United States.
  • NewsRx. University of Miami Describes Findings in Cancer (Mechanism and applications of magnetoelectric nanoparticles in cancer therapy). Cancer Weekly. October 14, 2025; p 1828.

Read more